Verdence Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.79M Sell
31,877
-4,303
-12% -$1M 0.45% 43
2025
Q4
$7.49M Sell
36,180
-1,946
-5% -$385K 0.44% 50
2025
Q3
$7.26M Sell
38,126
-5,586
-13% -$957K 0.42% 50
2025
Q2
$6.68M Sell
43,712
-3,478
-7% -$535K 0.46% 50
2025
Q1
$7.83M Buy
47,190
+1,891
+4% +$296K 0.6% 37
2024
Q4
$6.55M Sell
45,299
-189
-0.4% -$29.3K 0.53% 40
2024
Q3
$7.37M Buy
45,488
+8,480
+23% +$1.35M 0.59% 37
2024
Q2
$5.41M Sell
37,008
-4,118
-10% -$612K 0.48% 48
2024
Q1
$6.51M Sell
41,126
-23,600
-36% -$3.76M 0.59% 41
2023
Q4
$10.1M Buy
64,726
+710
+1% +$109K 0.98% 14
2023
Q3
$9.97M Buy
64,016
+4,450
+7% +$734K 1.08% 10
2023
Q2
$9.86M Buy
59,566
+479
+0.8% +$77.3K 1.14% 9
2023
Q1
$9.16M Buy
59,087
+410
+0.7% +$66.2K 1.11% 11
2022
Q4
$10.4M Sell
58,677
-935
-2% -$161K 1.27% 12
2022
Q3
$9.74M Buy
59,612
+1,614
+3% +$273K 1.34% 7
2022
Q2
$10.3M Sell
57,998
-7,426
-11% -$1.32M 1.33% 7
2022
Q1
$11.6M Buy
65,424
+6,138
+10% +$1.04M 1.31% 9
2021
Q4
$10.1M Buy
59,286
+652
+1% +$107K 1.19% 11
2021
Q3
$9.47M Sell
58,634
-377
-0.6% -$64.3K 1.25% 9
2021
Q2
$9.72M Buy
59,011
+2,932
+5% +$485K 1.35% 9
2021
Q1
$9.22M Buy
56,079
+2,298
+4% +$372K 1.55% 6
2020
Q4
$8.46M Buy
53,781
+2,287
+4% +$337K 1.6% 6
2020
Q3
$7.67M Buy
51,494
+245
+0.5% +$36.3K 1.76% 6
2020
Q2
$7.21M Sell
51,249
-3,669
-7% -$535K 1.78% 6
2020
Q1
$7.2M Buy
54,918
+2,015
+4% +$286K 2.15% 4
2019
Q4
$7.72M Sell
52,903
-59
-0.1% -$8K 1.89% 6
2019
Q3
$6.85M Buy
52,962
+1,145
+2% +$151K 1.93% 4
2019
Q2
$7.22M Sell
51,817
-8,969
-15% -$1.24M 2.07% 3
2019
Q1
$8.5M Sell
60,786
-14,469
-19% -$1.94M 2.3% 3
2018
Q4
$9.71M Sell
75,255
-2,471
-3% -$345K 2.72% 4
2018
Q3
$10.7M Buy
77,726
+3,445
+5% +$458K 2.66% 3
2018
Q2
$9.01M Buy
74,281
+5,767
+8% +$719K 2.19% 4
2018
Q1
$8.78M Buy
68,514
+17,619
+35% +$2.38M 2.11% 6
2017
Q4
$7.11M Buy
+50,895
New +$7.09M 1.7% 16

Other funds holding JNJ

Verdence Capital Advisors's JNJ Position: Q1 2026 in Review

Verdence Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, selling an estimated $1M and leaving 31,877 shares worth $7.79M. The position accounts for 0.45% of the portfolio, ranked #43.

Verdence Capital Advisors first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $11.6M in Q1 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Verdence Capital Advisors held 31,877 shares of Johnson & Johnson worth $7.79M as of Q1 2026.
  • Verdence Capital Advisors sold 4,303 Johnson & Johnson shares in Q1 2026, an estimated $1M.
  • Johnson & Johnson made up 0.45% of Verdence Capital Advisors's portfolio in Q1 2026, its #43 holding.
  • Verdence Capital Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • Verdence Capital Advisors's Johnson & Johnson position peaked at $11.6M in Q1 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.